USPSTF against screening for asymptomatic carotid stenosis
the US Prev Serv Taskforce updated their 2007 recommendation, reiterating their conclusion that we should not be doing routine screening for asymptomatic carotid artery stenosis, finding there is moderate-to-high certainty that risks outweigh benefits (see carotid artery stenosis screening asx uspstf 2014 in dropbox, or doi:10.7326/M14-1333). though noting the burden of morbidity/mortality associated with stroke, they also point out:
--asymptomatic carotid stenosis is assoc with a small proportion of strokes
--the most feasible test is ultrasound, with high sensitivity and specificity in studies, but in practice will lead to many false positives in the general population (where the prevalence of carotid stenosis is low -- best estimate is that 0.5-1.0% of population has stenosis >70%)
--there are no studies showing benefit of screening, and older studies (see below) showing the advantage of surgery (esp carotid endarterectomy, or CEA) over medical therapy decreased the absolute incidence of stroke by only 3.5%, though medical management now is better than at the time of the studies thereby decreasing likely benefit of surgery
--CEA has a 30-day stroke or mortality rate of 2.4% (higher in low volume centers), and MI rate of 0.8-2.2%. so, if many false positives are picked up by ultrasound, this translates into significant potential harm
--there is no valid instrument which identifies high-risk individuals (though the usual suspects are the traditional cardiovascular risk factors).
so, i think the argument against screening is pretty strong, and personally have never adopted routine carotid artery screening into my practice, but i think it is useful to point out the following:
--carotid artery stenosis in an individual puts them at higher risk of cardiovascular disease (basically, any atherosclerotic disease, including peripheral arterial or carotid disease, makes it more likely the person has asymptomatic coronary artery disease). this is incorporated into the new AHA algorithm -- though as TIA or stroke (i am making a small logical leap that asymptomatic carotid disease also confers higher heart disease risk, but this is true with peripheral arterial disease, where even asymptomatic people with low ankle-brachial index have higher risk of coronary artery disease)
--the presence of the carotid stenosis therefore would lead to more aggressive general atherosclerotic risk reduction, including more aggressive statin therapy and heightened awareness to control blood pressure, reduce smoking, use of aspirin/anti-platelet drug, etc
--the older studies finding benefit of CEA over medical therapy (eg the Asymptomatic Carotid Atherosclerosis Study, Asymptomatic Carotid Surgery Trial, the VA Cooperative Study) were somewhat flawed in that not all the participants really had asymptomatic disease, they involved highly trained surgeons in major centers who demonstrated very low levels of CEA-associated morbidity/mortality, and there were some differences in medical therapy (though they all included aspirin). but,
--these studies did show a strong relative risk reduction of stroke in the short term (studies were <4 years), and the 50% decrease the found in stroke/TIA after CEA might translate to a higher absolute risk reduction over time (in fact the ACST trial found continued benefit 9 years after the intervention)
--the control groups did get antiplatelet therapy (ie NOT placebo), and per standard-of-therapy at this time, the presence of carotid stenosis does lead at least to aggressive medical intervention (esp statins, antiplatelet agents), so not finding the carotid stenosis through screening is very likely to lead to lower uses of these medical therapies and potentially more strokes (and heart attacks...)
--and, these trials and the USPSTF recommendations are based on finding stenosis and then having surgery (CEA, or even stenting). but since medical management is far superior now to the time of these studies, and there are some pretty reasonable epidemiologic data to support that our increasing use of aggressive medical therapies for heart disease prevention also decreases TIA/stroke, my guess is that a study finding asymptomatic carotid artery stenosis with randomization to aggressive medical therapy vs routine care would find benefit to screening with much less risk than the surgical interventions
again, i do not do routine carotid stenosis screening, but the recommendations are a bit narrow in their scope, since carotid stenosis is associated with more than brain effects, and the perhaps most useful study (medical therapy vs placebo or routine care) has not been done
Comments
Post a Comment
if you would like to receive the near-daily emails regularly, please email me at gmodest@uphams.org